3M Co (MMM) stock
MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 20, 2026Score 14/3020% above fair value
$186.24−2.64 (-1.40%)
Close on Nov 12, 2026Market cap $96.24BP/E 27.8Yield 1.57%
3M EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
3M's EPS for the twelve months ending Sep 30, 2026 was $6.71, up 7.2% year over year. For fiscal 2025 it was $6.00, down 20.5% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $10.18 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.00 | -20.5% |
| FY2024 | Dec 31, 2024 | $7.55 | – |
| FY2023 | Dec 31, 2023 | -$12.63 | -224.1% |
| FY2022 | Dec 31, 2022 | $10.18 | +0.6% |
| FY2021 | Dec 31, 2021 | $10.12 | +8.1% |
| FY2020 | Dec 31, 2020 | $9.36 | +21.2% |
| FY2019 | Dec 31, 2019 | $7.72 | -13.2% |
| FY2018 | Dec 31, 2018 | $8.89 | +12.1% |
| FY2017 | Dec 31, 2017 | $7.93 | -2.8% |
| FY2016 | Dec 31, 2016 | $8.16 | +7.7% |
| FY2015 | Dec 31, 2015 | $7.58 | +1.2% |
| FY2014 | Dec 31, 2014 | $7.49 | +11.5% |
| FY2013 | Dec 31, 2013 | $6.72 | +6.3% |
| FY2012 | Dec 31, 2012 | $6.32 | +6.0% |
| FY2011 | Dec 31, 2011 | $5.96 | +5.9% |
| FY2010 | Dec 31, 2010 | $5.63 | +24.6% |
| FY2009 | Dec 31, 2009 | $4.52 | -7.6% |
| FY2008 | Dec 31, 2008 | $4.89 | -12.7% |
| FY2007 | Dec 31, 2007 | $5.60 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.63 | +69.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.78 | +32.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.23 | -39.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.07 | -19.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.55 | -37.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.34 | -35.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.04 | +22.2% |
| Q4 FY2024 | Dec 31, 2024 | $1.33 | -21.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.48 | – |
| Q2 FY2024 | Jun 30, 2024 | $2.07 | – |
| Q1 FY2024 | Mar 31, 2024 | $1.67 | -5.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.70 | +73.5% |
| Q3 FY2023 | Sep 30, 2023 | -$3.74 | -155.2% |
| Q2 FY2023 | Jun 30, 2023 | -$12.35 | -8921.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.76 | -22.1% |
| Q4 FY2022 | Dec 31, 2022 | $0.98 | -57.6% |
| Q3 FY2022 | Sep 30, 2022 | $6.77 | +176.3% |
| Q2 FY2022 | Jun 30, 2022 | $0.14 | -94.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.26 | -18.4% |
| Q4 FY2021 | Dec 31, 2021 | $2.31 | -2.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.45 | 0.0% |
| Q2 FY2021 | Jun 30, 2021 | $2.59 | +15.1% |
| Q1 FY2021 | Mar 31, 2021 | $2.77 | +23.1% |
| Q4 FY2020 | Dec 31, 2020 | $2.38 | +43.4% |
| Q3 FY2020 | Sep 30, 2020 | $2.45 | -9.9% |
| Q2 FY2020 | Jun 30, 2020 | $2.25 | +17.2% |
| Q1 FY2020 | Mar 31, 2020 | $2.25 | +49.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.66 | -26.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.72 | +5.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.92 | -37.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.51 | +54.1% |
| Q4 FY2018 | Dec 31, 2018 | $2.27 | +167.1% |
| Q3 FY2018 | Sep 30, 2018 | $2.58 | +10.7% |
| Q2 FY2018 | Jun 30, 2018 | $3.07 | +19.0% |
| Q1 FY2018 | Mar 31, 2018 | $0.98 | -54.6% |
| Q4 FY2017 | Dec 31, 2017 | $0.85 | -54.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.33 | – |
| Q2 FY2017 | Jun 30, 2017 | $2.58 | – |
| Q1 FY2017 | Mar 31, 2017 | $2.16 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.88 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?